Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-22.81	-217.45	281.69
Graham Fair Price	13.21	30.40	26.85
PEG	8.07	0.45	-0.41
Price/Book	-6.99	1.09	1.17
Price/Cash Flow	-18.28	31.51	38.55
Prices/Earnings	-19.48	10.35	12.85
Price/Sales	-3.20	5.24	5.41
Price/FCF	-18.28	31.51	38.55
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-75.43	0.20	0.80
ROA	21.63	< 0.005	< 0.005
ROE	0.02	0.03	15.51
ROIC	0.08	0.02	-80.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.19	7.78	-97.58
Dividends QOQ	-0.03	< 0.005	-92.50
EBIT QOQ	3.19	-0.75	-76.42
EPS QOQ	-0.31	0.23	-25.49
FCF QOQ	-0.40	0.20	-50.89
Revenue QOQ	0.56	0.01	-98.22
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	28.80	28.88	0.30
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.45	0.48	7.20
Quick Ratio	0.94	0.42	-54.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	37.56	39.56	5.34
Cash	84.87	83.88	-1.17
Capex	-0.20	-0.20	-3.66
Free Cash Flow	1.14	1.36	19.89
Revenue	8.11	8.21	1.21
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.26	0.12	-52.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	79.28	-73.52	-7.26
Naive Interpretation	Member

06 - Financial Health · Bad

Rating